FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094344 [Registered on: 08/09/2025] Trial Registered Prospectively
Last Modified On: 05/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Phaltrikadi Ghanvati will be given to patients of Diabetes Mellitus. 
Scientific Title of Study   Standard Controlled Clinical Evaluation of Phaltrikadi Ghanvati in Madhumeha (NIDDM) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rajni 
Designation  Pg Scholar Kayachikitsa Department 
Affiliation  Uttarakhand Ayurved University Gurukul Campus Haridwar Uttarakhand  
Address  OPD 5 Department of Kayachikitsa Uttarakhand Ayurved University,Gurukul Campus Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  8126208756  
Fax    
Email  rajni.pauri24@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dinesh Kumar Goyal 
Designation  Professor 
Affiliation  Uttarakhand Ayurved University Gurukul Campus Haridwar 
Address  OPD 5 Department of kayachikitsa uttarakhand ayurved university,Gurukul Campus,Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  9411731180  
Fax    
Email  dineshdr157@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rajni 
Designation  PG Scholar 
Affiliation  Uttarakhand ayurved university gurukul campus haridwar  
Address  OPD 5 Department of kayachikitsa uttarakhand ayurved university,Gurukul Campus Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  8126208756  
Fax    
Email  rajni.pauri24@gmail.com  
 
Source of Monetary or Material Support  
Department of P.G.kaychikitsa,uttarakhand ayurved university,gurukul campus,Haridwar 249404 India 
 
Primary Sponsor  
Name  Rajni 
Address  OPD 5 Department of kayachiktsa,uttarakhand ayurved university,gurukul campus haridwar uttarakhand 249404,India 
Type of Sponsor  Other [SELF ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rajni  Uttarakhand ayurved university Gurukul campus Haridwar  OPD 5 Department of kayachikitsa uttarakhand ayurved university gurukul campus Haridwar
Hardwar
UTTARANCHAL 
08126208756

rajni.pauri24@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE UTTARAKHAND AYURVED UNIVERSITY GURUKUL CAMPUS HARIDWAR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E118||Type 2 diabetes mellitus with unspecified complications. Ayurveda Condition: DIA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugOther than Classical(1) Medicine Name: BGR-34, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Phaltrikadi Ghanvati, Reference: charak chikitsa 6/40, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patient willing to sign the consent form.
2.Fasting blood glucose level more than or equal to 126mg per dl to less than or equal to 200mg per dl
3.Post prandial blood sugar level more than or equal to 200mg per dl to less than or equal to 300 mg per dl
4.HbA1c more than or equal to 6.5 percentage to less than or equal to 9 percentage. 
 
ExclusionCriteria 
Details  1.Patients of type 1 Diabetes Mellitus.
2.Patients having past history of MI,unstable angina or stroke.
3.Patients suffering from AIDS,cancer,tuberculosis,psychiatric illness.
4.pregnant and lactating women. 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
relief in subjective parameters.
1. Prabhutmutrata(polyuria)
2.Trishnadhikya(polydipsia)
3.Kshudhadhikya(polyphagia)
4.Daurbalya(weakness)
5.Kara-pada-taladaha(burning sensation of both palms and feet)
6.Avilmutrata(turbidity in urine) 
4-6 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
relief in objective parameters.
1.Blood sugar fasting
2.Blood sugar post prandial
3.HbA1c  
Assessment will be done on 0th day,30 day,60 day & 90 day for FBS & PPBS.And Hba1c will be done on 0th day & 90day. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   THIS STUDY IS STANDARD CONTROLLED CLINICAL EVALUATION OF PHALTRIKADI GHANVATI IN MADHUMEHA (NIDDM) FOR AGE GROUP BETWEEN 20 TO 70 YEARS FOR A DURATION OF 90 DAYS. THE STUDY WILL BE CONDUCTED AT UAU GURUKUL CAMPUS HARIDWAR ON 40 PATIENTS. IN THIS STUDY 20 PATIENTS WILL BE ADMINISTERED PHALTRIKADI GHANVATI AND 20 PATIENTS WILL BE ADMINISTERED BGR-34 FOR 90 DAYS. THE ASSESSMENT WILL BE DONE ON THE BASIS OF SUBJECTIVE AND OBJECTIVE PARAMETERS. THE STUDY WILL BE CONDUCTE AT OPD/IPD  LEVEL OF PG DEPARTMENT OF KAYACHIKITSA. THE ASSESSMENT WILL BE DONE AT THE INTERVAL OF 30 DAYS OF THE CLINICAL TRIAL AND THE RESULTS OBTAINED WILL BE TABULATED AND STATISTICALLY ANALYZED USING APPROPRIATE TESTS.   
Close